FDA Rejects Applied Therapeutics’ Galactosemia Drug, Govorestat, Shares Plunge 84%

Galactosemia is a rare genetic disorder that prevents the body from metabolizing galactose, a simple sugar.

New York: Applied Therapeutics announced on Wednesday that the U.S. Food and Drug Administration (FDA) has declined to approve its drug, govorestat, designed to treat galactosemia, a rare genetic metabolic disorder. This setback has cast a shadow over the company’s ambitions for its first commercial product, leading to an 84% drop in its stock price after hours.

In a letter to Applied Therapeutics, the FDA stated that the marketing application for govorestat could not be approved in its current form due to certain deficiencies. The company is now reviewing the feedback from the FDA and plans to request a meeting to discuss the necessary steps for resubmitting the application or potentially appealing the decision.

The FDA had previously delayed its decision on govorestat in March, in order to further review supplemental analyses submitted by the company.

Galactosemia is a rare genetic disorder that prevents the body from metabolizing galactose, a simple sugar. The inability to properly process galactose leads to its conversion into a toxic substance called galactitol, which can cause severe neurological complications. These may include impairments in speech, cognition, behavior, and motor skills. The disease affects approximately 3,000 patients in the United States, according to Applied Therapeutics.

Also Read | The Secret to Dinosaur Supremacy Found in Fossilized Feces and Vomit

Applied Therapeutics based its application for govorestat on data from a late-stage study, which showed that the drug significantly reduced galactitol levels in pediatric patients. The application also included data from a mid-stage study involving adult patients.

Also Read | Cuban Sugar Industry Decline Reflects Broader Food Crisis

Meanwhile, govorestat’s marketing application is under review by the European Union’s drugs regulator.

Recent News

India Loses a Star: Dr. K Kasturirangan Dies at 84

Thiruvananthapuram: India mourns the loss of one of its most revered scientific minds, Dr. Krishnaswamy Kasturirangan, former chairman of ISRO and chief architect of...

Nike Faces Lawsuit Over Closure of Crypto Business and Losses from Nike-Themed NFTs

New York: Nike is facing a proposed class action lawsuit filed by purchasers of Nike-branded non-fungible tokens (NFTs) and other cryptocurrency assets. The plaintiffs,...

Virginia Giuffre, Epstein Whistleblower and Abuse Survivor, Found Dead

Canberra : Virginia Giuffre, widely recognized as one of the most courageous voices in the fight against sexual abuse and human trafficking, has died...

Migrants Turn to UN for Help Returning Home Amid Sharp Drop in U.S. Border Crossings

Danali, Honduras: A growing number of migrants, discouraged by U.S. President Donald Trump's border enforcement policies, are abandoning their efforts to reach the United...